streptokinase

1. Comparison of Curative Effect of Reteplase and Recombinant Streptokinase in the Patients with ST-Elevation Myocardial Infarction
   急诊应用瑞替普酶、重组链激酶溶栓治疗ST段抬高型心肌梗死临床分析
2. Several clinically important enzymes and proteins that include bovine serum albumin, streptokinase, chymotrypsin, dispase, glucose oxidase ( GOD) etc., have been immobilized based on this method.
   借助于此方法，一些临床上重要的酶和蛋白如小牛血清白蛋白、溶栓酶、糜蛋白酶、中性蛋白酶、葡萄糖氧化酶（GOD）等已能被很好的固定。
3. A Comparative Study on Recombinant Streptokinase and Urokinase in Treatment of Acute Myocardial Infarction
   重组链激酶与尿激酶治疗急性心肌梗死的对比研究
4. For patients with acute ischemic stroke, we recommend against streptokinase ( Grade1A).
   急性缺血性卒中患者，推荐不用链激酶（1A级）。
5. Conclusion Domestic recombinant streptokinase is an effective, reliable and safe thrombolytic agent.
   结论国产重组链激酶为治疗急性心肌梗塞有效、安全的溶栓药物。
6. Intrapleural streptokinase for pleural infection A step forward in managing pleural effusions?
   胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步吗？
7. The Clinical Observation of Recombinant Streptokinase Joint Clopidogrel for Patients with Acute Myocardial Infarction
   氯吡格雷联合重组链激酶溶栓治疗急性心肌梗死的临床研究
8. To test this hypothesis, we evaluated the effect of low-dose intracoronary streptokinase administered immediately after primary PCI.
   为了检验该假说，我们评估在首次经皮冠脉介入后立即冠状动脉内注射低剂量的链激酶的效果。
9. CONCLUSIONS The intrapleural administration of streptokinase does not improve mortality, the rate of surgery, or the length of the hospital stay among patients with pleural infection.
   结论在胸膜感染的病人中，链激酶胸膜腔内给药不能改善死亡率、术率或住院时间的长短。
10. We conducted a trial to clarify the therapeutic role of intrapleural streptokinase.
    我们进行了一项试验，以阐明胸膜腔内应用链激酶的治疗作用。
11. Comparison of Streptokinase Sealing and Normal Saline Sealing for Prevention of Blockage of PICC in Leukemia Patients
    尿激酶与生理盐水封管预防白血病患者PICC堵管对照研究
12. Objective To compare the thrombolytic efficacy of native recombinant staphylokinase ( r-SAK), recombinant streptokinase ( r-SK) and urokinase ( UK) in equivalent doses for femoral artery thrombosis in rabbits.
    目的观察同等剂量国产重组葡激酶（r-SAK）、重组链激酶（r-SK）和尿激酶（UK）对兔股动脉血栓的溶栓疗效。
13. Refer to the fibrin plate assay and the clot lysis assay for determining the activities of streptokinase and urokinase, we established an assay for the activity determination of plasminogen.
    参照测定纤溶酶原活力的纤维平板法和测定链激酶及尿激酶活力的纤蛋白溶解气泡上升法，建立了一种快速测定人纤溶酶原活力的方法。
14. Objective Acute myocardial infarction ( AMI) is an emergency of cardio-vascular system. streptokinase ( SK) and urokinase ( UK) are widely used in the treatment for AMI.
    目的急性心肌梗死（AMI）是心血管急症这一，链激酶（SK）、尿激酶（UK）同属第一代溶栓剂，在我国AMI临床治疗中应用广泛。
15. Effect of intravenous thrombolytic therapy of streptokinase on early acute myocardial infarction
    链激酶静脉溶栓治疗早期急性心肌梗死疗效分析
16. Clinical analysis of streptokinase for treatment of acute myocardial infarction with different intravenous thrombolysis methods
    链激酶不同给药方法静脉溶栓治疗急性心肌梗死的临床疗效
17. Methods: Thirty-four patients with AMI were treated by intravenous thrombolytic therapy of streptokinase under electrocardiogram monitoring.
    方法：在心电图监测下，对34例急性心肌梗死患者行链激酶静脉溶栓治疗。
18. Isolation of Streptokinase Gene and Its Expression in Escherichia coli and Purification
    链激酶基因的分离和其在大肠杆菌中的表达及表达产物的纯化
19. Clinical study of therapy for acute cerebral infarction through local intra-arterial infusion with recombinant streptokinase
    局部动脉内灌注重组链激酶治疗急性脑梗死的临床研究
20. A comparison of thrombolytic effects of recombinant staphylokinase and recombinant streptokinase on arterial emboli in pigs
    基因重组葡激酶和重组链激酶在猪急性脑栓塞模型中溶栓作用的比较研究
21. Use of recombinant streptokinase in treatment of hypertensive cerebral hemorrhage
    基因重组链激酶在高血压脑性出血抽吸中的应用
22. [ Conclusion] The recombinant streptokinase can better dissolve intracerebral hematoma, improve the curative effect and meliorate prognosis.
    【结论】r-sk能更好地溶解、引流脑内血肿，提高疗效，改善预后。
23. Urokinase vs streptokinase in treating acute myocardial infarction
    尿激酶与链激酶治疗急性心肌梗死的比较
24. OBJECTIVE: To compare the efficacy and safety of China made gene recombined Streptokinase ( rSK) and German made streptokinase ( SK) in the treatment of acute myocardial infarction ( AMI).
    对比分析国产基因重组链激酶和德国链激酶静脉溶栓治疗急性心肌梗塞（AMI）的有效性和安全性。
25. Changes of Plasma Fibrinolytic Activities and Vasoactive Substances in Patients With Acute Myocardial Infarction After Thrombolytic Therapy by Recombinant Streptokinase
    重组链激酶溶栓治疗后急性心肌梗死患者纤溶活性及血管活性物质的改变
26. The assisting effect of berberine on urokinase and streptokinase induced thrombolysis
    小檗碱对尿激酶和链激酶引发的溶栓作用的协助
27. Objective To pool the data of randomized controlled trials ( RCT) that compared recombinant tissue-type plasminogen activator ( rt-PA) with urokinase ( UK) or streptokinase ( SK) in human pulmonary thromboembolism ( PTE) and evaluate the efficacy and safety of different thrombolytics.
    目的根据现有临床研究评价重组组织型纤溶酶原激活剂（rtPA）与链激酶（SK）/尿激酶（UK）治疗肺血栓栓塞症（PTE）的有效性和安全性。
28. Effect on blood coagulation function and toxicity of recombinant streptokinase in rats
    重组链激酶对大鼠凝血功能的影响及其毒性
29. Purpose To evaluate the efficacy and safety of intravenous recombinant streptokinase ( r-SK) in treatment of patients with acute deep veinous thrombosis of the lower limbs ( ADVT).
    目的观察国产重组链激酶（rSK）对下肢急性深静脉血栓形成的疗效和安全性。
30. The comparison of the repass rate between homemade recombined streptokinase and urokinase in thrombolytic therapy of acute myocardial infarction
    国产重组链激酶与尿激酶在急性心肌梗死溶栓中的血管再通率的比较

noun

1. an enzyme produced by some strains of streptococcus that can liquefy blood clots by converting plasminogen to plasmin